ENDRA Life Sciences (NDRA) Competitors $4.84 -0.44 (-8.33%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.84 0.00 (-0.10%) As of 08/1/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. OSRH, PETV, NXGL, IINN, XAIR, BDMD, DHAI, MHUA, INBS, and LYRAShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include OSR (OSRH), PetVivo (PETV), NexGel (NXGL), Inspira Technologies OXY B.H.N. (IINN), Beyond Air (XAIR), Baird Medical Investment (BDMD), DIH Holding US (DHAI), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Its Competitors OSR PetVivo NexGel Inspira Technologies OXY B.H.N. Beyond Air Baird Medical Investment DIH Holding US Meihua International Medical Technologies Intelligent Bio Solutions Lyra Therapeutics ENDRA Life Sciences (NASDAQ:NDRA) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Do analysts recommend NDRA or OSRH? ENDRA Life Sciences currently has a consensus target price of $50.00, indicating a potential upside of 933.06%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe ENDRA Life Sciences is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor NDRA or OSRH? In the previous week, OSR had 6 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 7 mentions for OSR and 1 mentions for ENDRA Life Sciences. OSR's average media sentiment score of 0.25 beat ENDRA Life Sciences' score of -1.00 indicating that OSR is being referred to more favorably in the news media. Company Overall Sentiment ENDRA Life Sciences Negative OSR Neutral Do institutionals and insiders believe in NDRA or OSRH? 1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by company insiders. Comparatively, 33.7% of OSR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings and valuation, NDRA or OSRH? OSR has lower revenue, but higher earnings than ENDRA Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$11.51M-$172.04-0.03OSR-$148.95K-83.12-$2.41MN/AN/A Which has more risk and volatility, NDRA or OSRH? ENDRA Life Sciences has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500. Comparatively, OSR has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Is NDRA or OSRH more profitable? OSR's return on equity of -36.89% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -140.96% -106.14% OSR N/A -36.89%-19.14% SummaryOSR beats ENDRA Life Sciences on 8 of the 12 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NDRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.97M$6.77B$5.48B$9.51BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-0.0320.9428.6723.80Price / SalesN/A54.14373.9066.58Price / CashN/A20.5035.4557.96Price / Book1.014.468.275.55Net Income-$11.51M$174.54M$3.24B$259.03M7 Day Performance-26.67%-5.27%-3.69%-4.59%1 Month Performance34.44%-3.94%4.33%4.46%1 Year Performance-99.93%8.26%25.95%18.03% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences1.4453 of 5 stars$4.84-8.3%$50.00+933.1%-99.9%$3.97MN/A-0.0320Positive NewsShort Interest ↑OSRHOSRN/A$0.94-3.7%N/AN/A$18.89MN/A0.00N/ANews CoveragePETVPetVivoN/A$0.77-3.8%N/A+30.2%$18.84M$1.05M-1.7120Gap DownNXGLNexGel0.5571 of 5 stars$2.28-3.4%N/A-12.9%$18.07M$8.69M-5.0710News CoverageGap DownHigh Trading VolumeIINNInspira Technologies OXY B.H.N.1.6583 of 5 stars$1.34-5.0%$2.00+49.3%+10.8%$17.80MN/A0.0020XAIRBeyond Air3.8467 of 5 stars$3.20flat$23.67+639.6%-74.0%$13.82M$3.70M-0.2070Short Interest ↑BDMDBaird Medical InvestmentN/A$2.10+2.9%N/AN/A$13.43MN/A0.00N/AGap DownDHAIDIH Holding US0.5974 of 5 stars$0.27+0.6%N/A-91.5%$12.71M$64.47M-0.90N/ANews CoverageMHUAMeihua International Medical Technologies1.4362 of 5 stars$0.39+3.0%N/A-59.9%$12.13M$96.90M0.00620Positive NewsGap UpINBSIntelligent Bio Solutions0.5811 of 5 stars$1.53-5.0%N/A+9.7%$11.13M$3.11M0.0010LYRALyra Therapeutics3.018 of 5 stars$7.80-1.9%$100.00+1,182.1%-57.0%$10.54M$1.19M-0.1350Positive News Related Companies and Tools Related Companies OSR Competitors PetVivo Competitors NexGel Competitors Inspira Technologies OXY B.H.N. Competitors Beyond Air Competitors Baird Medical Investment Competitors DIH Holding US Competitors Meihua International Medical Technologies Competitors Intelligent Bio Solutions Competitors Lyra Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NDRA Stock Alerts